NMPA Approval

Pegylated Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20258007

Registration Date

May 19, 2025

Previous Approval Numbers

国药准字S20210011

Drug Information

Generic Name

聚乙二醇化重组人粒细胞刺激因子注射液

Dosage Form

注射剂

Strength

1.0ml:3.0mg，活性为2.0×10^8IU/支（预装式注射器）

Drug Type

生物制品

Registration Date

May 19, 2025

Company Address

山东费县北外环路1号

Company Address

山东费县北外环路1号

Empowering clinical research with data-driven insights and AI-powered tools.

聚乙二醇化重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath